Last mentioned: Mar 24, 2026
The Trade Desk (TTD) and Solventum (SOLV) experienced significant share price declines on March 24, 2026, reflecting broader volatility in the SaaS and healthcare technology sectors. These movements underscore growing investor sensitivity to macroeconomic pressures and shifting regulatory landscapes affecting data-driven platforms.
The Trade Desk and Solventum experienced significant share price declines on March 24, 2026, driven by idiosyncratic headwinds. While TTD faces a high-stakes fee audit from Omnicom and an escalating feud with Publicis, Solventum continues to struggle with conservative 2026 growth guidance following its spin-off from 3M.
Solventum (SOLV) shares experienced a notable decline on Tuesday, reflecting investor concerns over the company's ability to maintain margins following its high-profile spin-off from 3M. The downward movement comes amid broader market volatility affecting growth-oriented healthcare technology and medical device firms.
Shares of programmatic advertising leader The Trade Desk (TTD) and healthcare spin-off Solventum (SOLV) experienced significant declines on March 24, 2026. The simultaneous slide suggests a macro-driven 'risk-off' sentiment affecting high-growth technology and newly independent entities alike.